| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.059 | 0.3 |